Page last updated: 2024-11-04

sarpogrelate and Active Hyperemia

sarpogrelate has been researched along with Active Hyperemia in 1 studies

sarpogrelate: structure given in first source

Research Excerpts

ExcerptRelevanceReference
" Forearm blood flow (FBF) and leg blood flow (LBF) responses to reactive hyperemia (RH) and sublingual administration of nitroglycerin (NTG) were measured using strain-gauge plethysmography."5.12Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease. ( Chayama, K; Goto, C; Higashi, Y; Miyazaki, M; Orihashi, K; Sanada, H; Sueda, T; Yoshizumi, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyazaki, M1
Higashi, Y1
Goto, C1
Chayama, K1
Yoshizumi, M1
Sanada, H1
Orihashi, K1
Sueda, T1

Trials

1 trial available for sarpogrelate and Active Hyperemia

ArticleYear
Sarpogrelate hydrochloride, a selective 5-HT2A antagonist, improves vascular function in patients with peripheral arterial disease.
    Journal of cardiovascular pharmacology, 2007, Volume: 49, Issue:4

    Topics: Aged; Aged, 80 and over; Analysis of Variance; Arterial Occlusive Diseases; Biomarkers; Endothelium,

2007